Upgrade to SI Premium - Free Trial

NRx Pharmaceuticals (NRXP)

4.08 +0.03 (0.74%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Osmind study finds IV ketamine more effective than nasal esketamine for depression June 5, 2026 8:52 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. June 5, 2026 8:50 AM - Globe NewsWire Form 8-K NRX Pharmaceuticals, For: Jun 03 June 4, 2026 5:20 PM - SEC Filing NRX Pharmaceuticals closes $22.3 million stock offering June 4, 2026 5:12 PM - StreetInsider NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option June 4, 2026 5:12 PM - Globe NewsWire Form 424B5 NRX Pharmaceuticals, June 3, 2026 4:11 PM - SEC Filing NRx Pharmaceuticals prices public offering at $3.50 per share June 3, 2026 8:18 AM - StreetInsider NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock June 3, 2026 8:18 AM - Globe NewsWire Form 8-K NRX Pharmaceuticals, For: Jun 02 June 2, 2026 5:30 PM - SEC Filing Form 424B5 NRX Pharmaceuticals, June 2, 2026 5:28 PM - SEC Filing NRx Pharmaceuticals announces proposed public offering of common stock June 2, 2026 4:01 PM - StreetInsider NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock June 2, 2026 4:01 PM - StreetInsider NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026 May 28, 2026 7:00 AM - StreetInsider HOPE Therapeutics deploys Zeta Surgical's FDA-cleared TMS system May 27, 2026 7:02 AM - StreetInsider NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System May 27, 2026 7:00 AM - Globe NewsWire NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System May 27, 2026 7:00 AM - StreetInsider Form 25-NSE NRX Pharmaceuticals, Filed by: Nasdaq Stock Market LLC May 22, 2026 4:18 PM - SEC Filing NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS May 18, 2026 7:52 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update May 18, 2026 7:00 AM - Globe NewsWire New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, May 16, 2026 7:05 AM - StreetInsider Form 10-Q NRX Pharmaceuticals, For: Mar 31 May 15, 2026 4:36 PM - SEC Filing Form SCHEDULE 13G/A NRX Pharmaceuticals, Filed by: Anson Funds Management LP May 15, 2026 12:29 PM - SEC Filing NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update May 14, 2026 7:00 AM - Globe NewsWire NRx Pharmaceuticals receives FDA clearance for depression trial May 7, 2026 8:01 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression an May 7, 2026 8:00 AM - Globe NewsWire NRX Pharmaceuticals begins commercial manufacturing for preservative-free ketamine May 5, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine May 5, 2026 7:00 AM - Globe NewsWire GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide May 1, 2026 2:30 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP) April 27, 2026 6:49 AM - StreetInsider New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global April 25, 2026 12:55 PM - StreetInsider NRx Pharmaceuticals receives FDA feedback on ketamine drug application April 22, 2026 7:04 AM - StreetInsider NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program April 22, 2026 7:00 AM - Globe NewsWire NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality April 20, 2026 7:00 AM - Globe NewsWire NRx Pharmaceuticals forms defense subsidiary for military therapy research April 15, 2026 7:01 AM - StreetInsider NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications April 15, 2026 7:00 AM - Globe NewsWire NRx Pharmaceuticals names Glenn Tyson as first Chief Commercial Officer April 13, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer April 13, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals receives FDA preliminary labeling approval for ketamine April 6, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application April 6, 2026 7:00 AM - Globe NewsWire Hope Therapeutics partners with Emobot to deploy AI depression monitoring March 30, 2026 7:00 AM - StreetInsider Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psych March 30, 2026 7:00 AM - StreetInsider New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX) March 28, 2026 11:00 AM - StreetInsider Form 8-K NRX Pharmaceuticals, For: Mar 23 March 24, 2026 4:32 PM - SEC Filing BTIG stays Buy rated on NRx Pharmaceuticals, Inc. (NRXP) as FDA waives additional clinical trials March 24, 2026 12:58 PM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress March 24, 2026 7:00 AM - StreetInsider Form 10-K NRX Pharmaceuticals, For: Dec 31 March 23, 2026 4:31 PM - SEC Filing New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST March 21, 2026 1:55 PM - StreetInsider NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026 March 19, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals receives FDA bioequivalence determination for ketamine March 17, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application March 17, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals receives FDA guidance for ketamine depression drug March 16, 2026 7:00 AM - StreetInsider NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting March 16, 2026 7:00 AM - StreetInsider New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST March 14, 2026 12:00 PM - StreetInsider HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD March 9, 2026 7:00 AM - StreetInsider New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA March 7, 2026 11:45 AM - StreetInsider Full Article List